Phase 2 Leiomyoma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT01799538
Recruiting
Phase 2
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Stage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8Renal Cell Carcinoma+3 more
National Cancer Institute (NCI)65 enrolled13 locationsNCT04981509
Recruiting
Phase 2
Effects of Simvastatin on Uterine Leiomyoma Size
LeiomyomaFibroid UterusFibroid Tumor+2 more
Johns Hopkins University60 enrolled1 locationNCT03400826
Recruiting
Phase 2
Doxycycline in Lymphanioleiomyomatosis (LAM): a randomised double blind placebo controlled crossover trial
Lymphangioleiomyomatosis
Dr.Deborah Yates30 enrolled1 locationACTRN12608000325303